"10.1371_journal.pone.0131242","plos one","2015-06-24T00:00:00Z","Siri T√§htinen; Saija Kaikkonen; Maiju Merisalo-Soikkeli; Susanna Gr√∂nberg-V√§h√§-Koskela; Anna Kanerva; Suvi Parviainen; Markus V√§h√§-Koskela; Akseli Hemminki","Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland","Conceived and designed the experiments: ST MV AH. Performed the experiments: ST SK MM SG SP. Analyzed the data: ST MV. Contributed reagents/materials/analysis tools: AK AH. Wrote the paper: ST MV AH.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: AH is shareholder of Oncos Therapeutics, Ltd. AH is employee in and shareholder of TILT Biotherapeutics Ltd, which has a patent pending in relation to information discussed in this article (Enhanced Adoptive Cell Therapy, PCT/EP2014/057776). SP is employee in TILT Biotherapeutics Ltd. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","06","Siri T√§htinen","ST√",8,TRUE,3,5,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
